AI

Neuroscience innovation
#AI #Alzheimer's #Artificial intelligence (AI) #Biomarkers #Brain disease #Drug discovery #Inherited tauopathies #Mental health #Nervous system disorders #Neurodegenerative disorders #Neurology #Neuroscience #Neurotechnology #Psychiatry #Tau protein

New podcast on innovation in neuroscience

This is the latest episode of the free DDW narrated podcast, titled “Where is the latest innovation in neuroscience?” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Taking a new approach to tackle neurodegenerative diseases,… Read More

#News

#AI #Biotech #Drug discovery #Generative AI

Genentech and NVIDIA partner to accelerate drug discovery with AI 

Biotechnology company Genentech has entered into a partnership with software group NVIDIA to use generative AI to discover and develop new therapeutics.   The collaboration will see experts from each company optimise and accelerate Genentech’s proprietary algorithms with goals to transform the discovery and development of new… Read More

#News

#AI #BioMap #Biotherapeutics #Collaboration #Sanofi

Collaboration to develop AI modules for biotherapeutics 

BioMap has entered a strategic collaboration with Sanofi to co-develop AI modules for biotherapeutic drug discovery, leveraging BioMap’s AI platform.  Traditional AI methods require vast amounts of labeled data to make accurate predictions. However, in life science, labeled data are often in short supply. BioMap’s foundational models… Read More

#News

#AI #Drug discovery #Generative AI #Machine learning

Generative AI and drug discovery: webinar

The webinar ‘Generative AI: Turning drug discovery into a technological pursuit’ supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President,… Read More

#News

AI concept
#AI #Generative AI #Machine learning #Webinar

Webinar: How AI is transforming drug discovery

This webinar supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President, Protein Sciences at Generate:Biomedicines who will discuss how an… Read More

#News

#AI #Drug discovery #Generative AI #Machine learning #Webinar

Generative AI webinar: Turning drug discovery into a technological pursuit

This webinar supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President, Protein Sciences at Generate:Biomedicines who will discuss how an… Read More

#News

ulcerative colitis
#AI #BenevolentAI #Drug discovery #Ulcerative colitis (UC)

First patients dosed with an AI-derived target for ulcerative colitis 

BenevolentAI has dosed the first patients in Phase I first-in-human studies of its oral phosphodiesterase 10 (PDE10) inhibitor, BEN-8744, intended for the treatment of ulcerative colitis (UC). The topline data readout from this study is expected in the first quarter of 2024.  UC is a chronic disease… Read More

#News

#AI #Cancer #CNS #FDA #Lantern Pharma #Solid tumours

FDA clearance of IND application for solid tumour drug 

Lantern Pharma, an AI company developing targeted and transformative cancer therapies, has received clearance from the US Food and Drug Administration (FDA) for the investigational new drug (IND) application for LP-184, which is being developed for multiple advanced solid tumours and central nervous system (CNS) cancers.   The… Read More

#News

AI brain partnership
#AI #Drug discovery #Innovation #Mental health #Partnership

Partnership targets hard-to-diagnose mental health conditions 

Pangaea Data has been awarded a strategic partnership by the newly established Mental Health Research for Innovation Centre (M-RIC).   Pangaea is a provider of a novel artificial intelligence (AI)-driven product for characterising patients by automatically discovering clinical signatures for 4,000 hard-to-diagnose conditions in an evolving, privacy-preserving and… Read More

#News

#AI #ALS #BenevolentAI #Drug discovery

BenevolentAI progresses drug for the potential treatment of ALS 

BenevolentAI, developers of AI that accelerates biopharma discovery, has delivered BEN-34712, its pre-clinical candidate for the potential treatment of amyotrophic lateral sclerosis (ALS).  BEN-34712 is an oral, potent and selective brain penetrant RARɑ𝛃 (retinoic acid receptor alpha beta) biased agonist and will now enter investigational new drug… Read More

#News

Lightbulb, ideas, innovation
#AI #Animal models #Animal testing #BioInnovation Institute #Data science #Drug discovery #Drug research #Microbiome #Regulatory

New podcast: Innovate to reinvent the future of drug discovery

This is the latest episode of the free DDW narrated podcast, “Innovating now to reinvent the future of drug discovery”. It covers three articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Predictive biomarkers in the… Read More

#News

Workcell with a microfluidic chip testing thousands of AI-designed proteins
#Adaptyv Bio #AI #Automation / robotics #Enzymes #Generative AI #Life sciences #Protein engineering #Technology

A new paradigm for protein engineering 

Adaptyv Bio, a Swiss/US technology company that develops infrastructure and tools for protein designers to engineer better proteins, has built a protein engineering foundry that it says will “pave the way” for protein designers to develop new medicines, novel enzymes and sustainable materials. AI tools like ChatGPT… Read More

#News

#Age-related diseases (ARDs) #Ageing #AI #Biotechnology #Business #Clinical trials #mRNA

Podcast: The impact of technology on drug discovery

This is the latest episode of the free DDW narrated podcast, “The impact of technology on drug discovery”. It covers two articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Talking Tech” and “Rejuvenation biotech: Can… Read More

#News

#AI #Biochemistry #Drug discovery #Lab automation #Molecular Biology #SLAS2022

Podcast covers the lab of the future

This is the latest episode of the free DDW podcast, “Painting a picture of the lab of the future”. It covers two articles written for the exclusive DDW & SLAS2022 supplement published in Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “Perspective: education and lab automation”… Read More

#News

#AI #Biobanking #Drug discovery #Genomics #Personalised medicine

Drug discovery hotspots: Focus on Qatar

DDW Editor Reece Armstrong takes a look at Qatar’s drug discovery and life sciences market, exploring how the country is utilising innovative technologies in its approach to healthcare.   The Middle East represents one of the world’s most lucrative markets for pharmaceuticals. Along with Africa, the Middle East stands as… Read More

#Exclusive Content #Market Reports